Hemacell Perfusion scientists provide consulting, subcontract, and training services to companies exploring the use of stem cells in therapeutic
applications with improved, proprietary methods for obtaining multipotent stem cells without destroying human embryos. An advantage of Hemacell Perfusions' proprietary method is the extraction of up to five times as many stem cells from a placenta or umbilical cord than has been achieved by
most current protocols.

Hemacell Perfusion is also available to consult on quality and process efficiency attributes of Cell Culture facilities, writing SOPs for cGMP compliance
and Lean Manufacturing techniques.